Gladius Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Gladius Therapeutics General Information

Description

Operator of a clinical-stage biopharmaceutical company intended to develop therapeutics that disrupt mitochondrial function in the cancer cell. The company's platform leverages proprietary knowledge of mitochondrial biology to identify and develop small molecule drugs that selectively disrupt cancer cell metabolism, offering to target cancer cells while minimizing harm to healthy tissues to develop therapeutics that disrupt mitochondrial function in the cancer cell, enabling the pharmaceutical market to offer novel and effective cancer treatment options.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2929 Arch Street
  • B+ Labs, Floor 2
  • Philadelphia, PA 19104
  • United States
+1 (215)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 2929 Arch Street
  • B+ Labs, Floor 2
  • Philadelphia, PA 19104
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gladius Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 22-Nov-2024 Completed Out of Business
1. Early Stage VC 21-Aug-2023 Completed Startup
To view Gladius Therapeutics’s complete valuation and funding history, request access »

Gladius Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gladius Therapeutics FAQs

  • When was Gladius Therapeutics founded?

    Gladius Therapeutics was founded in 2023.

  • Where is Gladius Therapeutics headquartered?

    Gladius Therapeutics is headquartered in Philadelphia, PA.

  • What is the size of Gladius Therapeutics?

    Gladius Therapeutics has 4 total employees.

  • What industry is Gladius Therapeutics in?

    Gladius Therapeutics’s primary industry is Drug Discovery.

  • Is Gladius Therapeutics a private or public company?

    Gladius Therapeutics is a Private company.

  • What is Gladius Therapeutics’s current revenue?

    The current revenue for Gladius Therapeutics is .

  • How much funding has Gladius Therapeutics raised over time?

    Gladius Therapeutics has raised $300K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process